C-reactive protein: Ligands, receptors and role in inflammation

Tillett, 1930, Serological reactions in pneumonia with a non-protein fraction of pneumococcus, J. Exp. Med., 52, 561, 10.1084/jem.52.4.561

Kaplan, 1974, Interactions of C-reactive protein with the complement system: I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal polysaccharide and with the choline phosphatides, lecithin and sphingomyelin, J. Immunol., 112, 2135, 10.4049/jimmunol.112.6.2135

Ridker, 2003, Clinical application of C-reactive protein for cardiovascular disease detection and prevention, Circulation, 107, 363, 10.1161/01.CIR.0000053730.47739.3C

Hurlimann, 1966, The liver as the site of C-reactive protein formation, J. Exp. Med., 123, 365, 10.1084/jem.123.2.365

Mackiewicz, 1991, Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines, J. Immunol., 146, 3032, 10.4049/jimmunol.146.9.3032

Agrawal, 2003, Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3, Immunology, 108, 539, 10.1046/j.1365-2567.2003.01608.x

Zhang, 1996, STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6, J. Biol. Chem., 271, 9503, 10.1074/jbc.271.16.9503

Agrawal, 2003, Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPbeta to the promoter, Mol. Immunol., 40, 373, 10.1016/S0161-5890(03)00148-2

Li, 1990, cis-Acting elements responsible for interleukin-6 inducible C-reactive protein expression, J. Biol. Chem., 265, 4136, 10.1016/S0021-9258(19)39713-3

Szalai, 2005, Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level, J. Mol. Med., 83, 440, 10.1007/s00109-005-0658-0

Szalai, 2002, Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene, Genes Immun., 3, 14, 10.1038/sj.gene.6363820

Russell, 2004, Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus, Hum. Mol. Genet., 13, 137, 10.1093/hmg/ddh021

Szalai, 2005, Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA): XXX. Association between C-reactive protein (CRP) gene polymorphisms and vascular events, Rheumatology (Oxford), 44, 864, 10.1093/rheumatology/keh613

Suk, 2005, Relation of polymorphism within the C-reactive protein gene and plasma CRP levels, Atherosclerosis, 178, 139, 10.1016/j.atherosclerosis.2004.07.033

Zee, 2002, Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis, Atherosclerosis, 162, 217, 10.1016/S0021-9150(01)00703-1

Eklund, 2005, Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors, Int. J. Immunogenet., 32, 229, 10.1111/j.1744-313X.2005.00515.x

Brull, 2003, Human CRP gene polymorphism influences CRP levels. Implications for prediction and pathogenesis of coronary heart disease, Arterioscler. Thromb. Vasc. Biol., 23, 2063, 10.1161/01.ATV.0000084640.21712.9C

Thompson, 1999, The physiological structure of human C-reactive protein and its complex with phosphocholine, Structure, 7, 169, 10.1016/S0969-2126(99)80023-9

Shrive, 1996, Three dimensional structure of human C-reactive protein, Nat. Struct. Biol., 3, 346, 10.1038/nsb0496-346

Agrawal, 2001, Topology and structure of the C1q-binding site on C-reactive protein, J. Immunol., 166, 3998, 10.4049/jimmunol.166.6.3998

Marnell, 1995, C-reactive protein binds to FcγRI in transfected COS cells, J. Immunol., 155, 2185, 10.4049/jimmunol.155.4.2185

Bang, 2005, Analysis of binding sites in human C-reactive protein for FcγRI, FcγRIIa and C1q by site-directed mutagenesis, J. Biol. Chem., 280, 25095, 10.1074/jbc.M504782200

Gaboriaud, 2003, The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties, J. Biol. Chem., 278, 46974, 10.1074/jbc.M307764200

Volanakis, 1971, Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide, Proc. Soc. Exp. Biol. Med., 136, 612, 10.3181/00379727-136-35323

Bodman-Smith, 2002, C-reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses, Parasite Immunol., 24, 447, 10.1046/j.1365-3024.2002.00486.x

Weiser, 1998, Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein, J. Exp. Med., 187, 631, 10.1084/jem.187.4.631

Ng, 2004, C-reactive protein: a predominant LPS-binding acute phase protein responsive to Pseudomonas infection, J. Endotoxin Res., 10, 163, 10.1177/09680519040100030301

Li, 1994, Sublytic complement attack exposes C-reactive protein binding sites on cell membranes, J. Immunol., 152, 2995, 10.4049/jimmunol.152.6.2995

Narkates, 1982, C-reactive protein binding specificities: artificial and natural phospholipid bilayers, Ann. N.Y. Acad. Sci., 389, 172, 10.1111/j.1749-6632.1982.tb22135.x

Kim, 2003, Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses, Ann. N.Y. Acad. Sci., 987, 68, 10.1111/j.1749-6632.2003.tb06034.x

Hanayama, 2004, Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice, Science, 304, 1147, 10.1126/science.1094359

Mold, 2002, Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcγ receptors, J. Autoimmun., 19, 147, 10.1006/jaut.2002.0615

Gershov, 2000, C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity, J. Exp. Med., 192, 1353, 10.1084/jem.192.9.1353

Gitlin, 1977, Localization of C-reactive protein in synovium of patients with rheumatoid arthritis, Arthritis Rheum., 20, 1491, 10.1002/art.1780200808

Robey, 1984, Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein, J. Biol. Chem., 259, 7311, 10.1016/S0021-9258(17)39873-3

Du Clos, 1988, Analysis of the binding of C-reactive protein to histones and chromatin, J. Immunol., 141, 4266, 10.4049/jimmunol.141.12.4266

Robey, 1985, C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro, J. Exp. Med., 161, 1344, 10.1084/jem.161.6.1344

Shephard, 1986, Functional effects of CRP binding to nuclei, Immunology, 58, 489

Du Clos, 1989, C-reactive protein reacts with the U1 small nuclear ribonucleoprotein, J. Immunol., 143, 2553, 10.4049/jimmunol.143.8.2553

Jewell, 1993, C-reactive protein (CRP) binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding region, Mol. Immunol., 30, 701, 10.1016/0161-5890(93)90141-W

Mold, 1981, C-reactive protein is protective against Streptococcus pneumoniae infection in mice, J. Exp. Med., 154, 1703, 10.1084/jem.154.5.1703

Mold, 1999, Regulation of complement activation by C-reactive protein, Immunopharmacology, 42, 23, 10.1016/S0162-3109(99)00007-7

Wolbink, 1996, CRP-mediated activation of complement in vivo, J. Immunol., 157, 473, 10.4049/jimmunol.157.1.473

Nijmeijer, 2003, C-reactive protein activates complement in infarcted human myocardium, Am. J. Pathol., 163, 269, 10.1016/S0002-9440(10)63650-4

Bhakdi, 2004, Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence, Circulation, 109, 1870, 10.1161/01.CIR.0000124228.08972.26

Du Clos, 2004, C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity, Immunol. Res., 30, 261, 10.1385/IR:30:3:261

Bodman-Smith, 2002, C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI), Immunology, 107, 252, 10.1046/j.1365-2567.2002.01481.x

Tebo, 1990, Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937, J. Immunol., 144, 231, 10.4049/jimmunol.144.1.231

Bharadwaj, 1999, The major receptor for C-reactive protein on leukocytes is Fcγ receptor II, J. Exp. Med., 190, 585, 10.1084/jem.190.4.585

Stein, 2000, C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific, J. Clin. Invest., 105, 369, 10.1172/JCI7817

Bodman-Smith, 2004, FcγRIIa expression with FcgammaRI results in C-reactive protein- and IgG-mediated phagocytosis, J. Leukocyte Biol., 75, 1029, 10.1189/jlb.0703306

Manolov, 2004, Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcγRIIa, Arterioscler. Thromb. Vasc. Biol., 24, 2372, 10.1161/01.ATV.0000147407.17137.02

Swanson, 2004, The coordination of signaling during Fc receptor-mediated phagocytosis, J. Leuk. Biol., 76, 1093, 10.1189/jlb.0804439

Chi, 2002, C-reactive protein induces signaling through FcγRIIa on HL-60 granulocytes, J. Immunol., 168, 1413, 10.4049/jimmunol.168.3.1413

Wang, 2005, Effect of C-reactive protein on gene expression in vascular endothelial cells, Am. J. Physiol.: Heart Circ. Physiol., 288, 1539, 10.1152/ajpheart.00963.2004

Zhong, 1998, Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling, J. Immunol., 161, 2533, 10.4049/jimmunol.161.5.2533

Devaraj, 2004, Effect of C-reactive protein on chemokine expression in human aortic endothelial cells, J. Mol. Cell. Cardiol., 36, 405, 10.1016/j.yjmcc.2003.12.005

Williams, 2004, C-reactive protein stimulates MMP-1 expression in U937 histocytes through FcγRII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization, Arterioscler. Thromb. Vasc. Biol., 24, 61, 10.1161/01.ATV.0000104014.24367.16

Bharadwaj, 2001, Serum amyloid P component binds to Fcγ receptors and opsonizes particles for phagocytosis, J. Immunol., 166, 6735, 10.4049/jimmunol.166.11.6735

Yother, 1982, Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice, J. Immunol., 128, 2374, 10.4049/jimmunol.128.5.2374

Szalai, 1995, Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice, J. Immunol., 155, 2557, 10.4049/jimmunol.155.5.2557

Horowitz, 1987, Blood clearance of Streptococcus pneumoniae by C-reactive protein, J. Immunol., 138, 2598, 10.4049/jimmunol.138.8.2598

Mold, 2002, Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ receptors, J. Immunol., 168, 6375, 10.4049/jimmunol.168.12.6375

Weiser, 1998, Adaptation of Haemophilus influenzae to acquired and innate immunity based on phase variation of lipopolysaccharide, Mol. Microbiol., 30, 767, 10.1046/j.1365-2958.1998.01108.x

Szalai, 2000, Human C-reactive protein is protective against fatal Salmonella enterica Serovar Typhimurium infection in transgenic mice, Infect. Immun., 68, 5652, 10.1128/IAI.68.10.5652-5656.2000

Mold, 2001, Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcγRs, J. Immunol., 166, 1200, 10.4049/jimmunol.166.2.1200

Pepys, 1979, Isolation of serum amyloid P-component (protein SAP) in the mouse, Immunol., 37, 637

Xia, 1997, Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia, Proc. Natl. Acad. Sci. U. S. A., 94, 2575, 10.1073/pnas.94.6.2575

Mold, 2002, C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR, J. Immunol., 169, 7019, 10.4049/jimmunol.169.12.7019

Tilg, 1993, Antiinflammatory properties of hepatic acute phase proteins: preferential induction of Interleukin 1 (IL-1) receptor antagonist over IL-1b synthesis by human peripheral blood mononuclear cells, J. Exp. Med., 178, 1629, 10.1084/jem.178.5.1629

Du Clos, 1994, Decreased autoantibody levels and enhanced survival of (NZB × NZW) F1 mice treated with C-reactive protein, Clin. Immunol. Immunopathol., 70, 22, 10.1006/clin.1994.1005

Rodriguez, 2005, Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein, Arthritis Rheum., 52, 642, 10.1002/art.20846

Szalai, 2003, Delayed lupus onset in (NZB × NZW) F1 mice expressing a human C-reactive protein transgene, Arthritis Rheum., 48, 1602, 10.1002/art.11026

Theofilopoulos, 1985, Murine models of systemic lupus erythematosus, Adv. Immunol., 37, 269, 10.1016/S0065-2776(08)60342-9

Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annu. Rev. Immunol., 19, 683, 10.1146/annurev.immunol.19.1.683

Groux, 2003, The complex role of interleukin-10 in autoimmunity, J. Autoimmun., 20, 281, 10.1016/S0896-8411(03)00044-1